RapidAI Announces $25 Million in Series B Funding to Expand AI-Enhanced Cerebrovascular Imaging Worldwide

SAN MATEO, Calif.--(BUSINESS WIRE)-- #ischemaview--RapidAI, the worldwide leader in advanced imaging for stroke, today announced a $25 million Series B round of funding by Lennertz & Co. Building on years of profitability, these additional funds will accelerate the company’s strategic growth initiatives around the world. Founded in 2011, RapidAI makes the most-widely used advanced cerebrovascular imaging products for patient care, research, and clinical trials. This funding will support the continued adva